{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:25:31Z","timestamp":1785194731137,"version":"3.55.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  BACKGROUND: The prevalence of primary sclerosing cholangitis (PSC) in the general population has not yet been clearly established. The management of PSC should focus on delaying the progression of the disease and restraining its complications. The only curative therapy for the disease remains liver transplantation (LT). PSC is currently the fifth most common indication for LT and corresponds to 5% of all LT indications in adults.  AIMS: Our objective is to evaluate the indications and outcomes of PSC patients undergoing LT in three liver transplantation centers in southern Brazil \u2013 Hospital Santa Isabel in Blumenau, Santa Catarina state, and Hospital das Cl\u00ednicas and Hospital Nossa Senhora das Gra\u00e7as, in Curitiba, Parana state).  METHODS: This is a longitudinal observational study of patients with PSC who underwent LT in three major Brazilian medical centers. Electronic medical records and study protocols of all patients subjected to LT from January 2011 to December 2021 were retrospectively reviewed.  RESULTS: Of the 1,362 transplants performed in the three medical centers, 37 were due to PSC. Recurrence of PSC occurred in three patients (8.1%) in 3.0\u00b12.4 years (range, 1\u20134 years). The 1-year and 5-year survival rates after the first LT were 83.8 and 80.6%, respectively. The 1-year and 5-year graft survival rates were, respectively, 83.8 and 74.8%.  CONCLUSIONS: Our experience with LT in patients with PSC demonstrated good patient and graft survival results. Most deaths were due to common factors in patients undergoing LT.<\/jats:p>","DOI":"10.1590\/0102-672020230051e1769","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:37:58Z","timestamp":1697197078000},"source":"Crossref","is-referenced-by-count":5,"title":["LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTRIC STUDY"],"prefix":"10.1590","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6357-8286","authenticated-orcid":false,"given":"Henrique de Aguiar","family":"Wiederkehr","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-2404","authenticated-orcid":false,"given":"Julio Cesar","family":"Wiederkehr","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil; Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0716-6089","authenticated-orcid":false,"given":"Mauro Rafael","family":"Da Igreja","sequence":"additional","affiliation":[{"name":"Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-9956","authenticated-orcid":false,"given":"Eduardo Brommelstroet","family":"Ramos","sequence":"additional","affiliation":[{"name":"Nossa Senhora das Gra\u00e7as Hospital,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8715-4154","authenticated-orcid":false,"given":"Marcelo Scheidemantel","family":"Nogara","sequence":"additional","affiliation":[{"name":"Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6382-046X","authenticated-orcid":false,"given":"Debora Stroparo","family":"Soffiatti","sequence":"additional","affiliation":[{"name":"Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3645-9726","authenticated-orcid":false,"given":"Andrew","family":"Massutti","sequence":"additional","affiliation":[{"name":"Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-1492","authenticated-orcid":false,"given":"Vivian La\u00eds","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Nossa Senhora das Gra\u00e7as Hospital,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2027-7658","authenticated-orcid":false,"given":"Barbara de Aguiar","family":"Wiederkehr","sequence":"additional","affiliation":[{"name":"Santa Isabel Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0270-9596","authenticated-orcid":false,"given":"Igor Raphael Mathias","family":"Valejo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7622-8592","authenticated-orcid":false,"given":"J\u00falio Cezar Uili","family":"Coelho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brazil; Nossa Senhora das Gra\u00e7as Hospital,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000548","article-title":"Indications and outcomes in liver transplantation in patients with primary sclerosing cholangitis in Norway","volume":"1","author":"Andersen IM","year":"2015","journal-title":"Transplant Direct"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1590\/0102-6720201700020011","article-title":"Biliary complications after liver transplantation","volume":"30","author":"Coelho JCU","year":"2017","journal-title":"ABCD Arq Bras Cir Dig"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1432-2277.2011.01371.x","article-title":"Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative","volume":"25","author":"Damrah O","year":"2012","journal-title":"Transpl Int"},{"issue":"4","key":"ref4","first-page":"611","article-title":"Quality of life after 10 years of liver transplantation","volume":"29","author":"Domingos MF","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa H","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"ref6","article-title":"Relationship between donor quality and recipient gravity in liver transplant","volume":"33","author":"Freitas ACT","year":"2020","journal-title":"Arq Bras Cir Dig"},{"key":"ref7","article-title":"Indication for liver transplantation due to hepatocellular carcinoma: analysis of 1,706 procedures over the past decade in the State of Paran\u00e1","volume":"35","author":"Freitas ACT","year":"2022","journal-title":"Arq Bras Cir Dig"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000347207","article-title":"Liver transplantation for perihilar cholangiocarcinoma","volume":"31","author":"Gores GJ","year":"2013","journal-title":"Dig Dis"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss JA","year":"1997","journal-title":"Ann Surg"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei IW","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand T","year":"2016","journal-title":"Liver Transpl"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0037-1608655","article-title":"Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis","volume":"37","author":"Martin EF","year":"2017","journal-title":"Semin Liver Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5604\/01.3001.0009.8598","article-title":"Ursodeoxycholic acid therapy in patients with primary biliary cholangitis with limited liver transplantation availability","volume":"16","author":"Melchor-Mendoza YK","year":"2017","journal-title":"Ann Hepatol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/tri.12513","article-title":"Meta-analysis of duct-to-duct versus Roux-en-Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis","volume":"28","author":"Pandanaboyana S","year":"2015","journal-title":"Transpl Int"},{"issue":"4","key":"ref15","article-title":"Risk factors associated with hepatic artery thrombosis: analysis of 1050 liver transplants","volume":"33","author":"Pinto LEV","year":"2021","journal-title":"Arq Bras Cir Dig"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar R","year":"2015","journal-title":"J Hepatol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1590\/1806-9282.20201088","article-title":"Liver transplantation: survival and indexes of donor-recipient matching","volume":"67","author":"Silveira F","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2013.163","article-title":"Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"108","author":"Singh S","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.transproceed.2003.09.017","article-title":"Liver transplantation for primary sclerosing cholangitis","volume":"35","author":"Solano E","year":"2003","journal-title":"Transplant Proc"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten IC","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","DOI":"10.1590\/0102-672020210001e1576","article-title":"Bar, Soft and DRI post-hepatic transplantation: what is the best for survival analysis?","volume":"34","author":"Torterolli F","year":"2021","journal-title":"Arq Bras Cir Dig"},{"issue":"9349","key":"ref22","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","author":"Vera A","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/tri.13925","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation \u2013 analysing the European Liver Transplant Registry and beyond","volume":"34","author":"Visseren T","year":"2021","journal-title":"Transpl Int"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/MIB.0000000000000065","article-title":"Hepatobiliary manifestations of inflammatory bowel disease","volume":"20","author":"Yarur AJ","year":"2014","journal-title":"Inflamm Bowel Dis"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["TRANSPLANTE HEP\u00c1TICO EM PACIENTES COM COLANGITE ESCLEROSANTE PRIM\u00c1RIA: ESTUDO MULTIC\u00caNTRICO"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202023000100333&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:38:07Z","timestamp":1697197087000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202023000100333&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":24,"alternative-id":["S0102-67202023000100333"],"URL":"https:\/\/doi.org\/10.1590\/0102-672020230051e1769","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"value":"2317-6326","type":"electronic"},{"value":"0102-6720","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e1769"}}